Ibere Pharmaceuticals is a blank check company.
Quote | Ibere Pharmaceuticals Class A (NYSE:IBER)
Last: | $10.18 |
---|---|
Change Percent: | 0.0% |
Open: | $10.18 |
Close: | $10.18 |
High: | $10.18 |
Low: | $10.18 |
Volume: | 44,499 |
Last Trade Date Time: | 03/01/2023 03:00:00 am |
News | Ibere Pharmaceuticals Class A (NYSE:IBER)
A look at the top 10 most actives in Canada BMO Long Federal Bond Index ETF (ZFL) rose 0.2% to $12.35 on volume of 10,056,021 shares Delta 9 Cannabis Inc. (DN) fell 16.7% to $0.025 on volume of 6,264,289 shares BMO Equal Weight Banks Index ETF (ZEB) rose 0.7% to $35.61 on volume of 4,183,...
Toronto, Ontario--(Newsfile Corp. - April 4, 2024) - IberAmerican Lithium Corp. (CBOE: IBER) (OTCQB: IBRLF) (" IberAmerican Lithium " or the " Company "), a company focused on the exploration of lithium, wishes to provide an update on the progress made with respect to the regulatory advancements ...
Message Board Posts | Ibere Pharmaceuticals Class A (NYSE:IBER)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Ibere Pharmaceuticals Class A Company Name:
IBER Stock Symbol:
NYSE Market:
A look at the top 10 most actives in Canada BMO Long Federal Bond Index ETF (ZFL) rose 0.2% to $12.35 on volume of 10,056,021 shares Delta 9 Cannabis Inc. (DN) fell 16.7% to $0.025 on volume of 6,264,289 shares BMO Equal Weight Banks Index ETF (ZEB) rose 0.7% to $35.61 on volume of 4,183,...
Toronto, Ontario--(Newsfile Corp. - April 4, 2024) - IberAmerican Lithium Corp. (CBOE: IBER) (OTCQB: IBRLF) (" IberAmerican Lithium " or the " Company "), a company focused on the exploration of lithium, wishes to provide an update on the progress made with respect to the regulatory advancements ...
Toronto, Ontario--(Newsfile Corp. - March 27, 2024) - IberAmerican Lithium Corp. (CBOE: IBER) (OTCQB: IBRLF) (" IberAmerican " or the " Company "), a company focused on the exploration of lithium, is pleased to announce that it has filed its audited consolidated financial statements and accompany...